17 June 2022
Cells | Top 10 Cited Papers in 2021 in the Section “Cells of the Nervous System”

The following are the 2021 top 10 cited papers from the Section “Cells of the Nervous System”, published in Cells (ISSN: 2073-4409):

1. “Astrocytes in Alzheimer’s Disease: Pathological Significance and Molecular Pathways”
Preman, P.; Alfonso-Triguero, M.; Alberdi, E.; Verkhratsky, A.; Arranz, A.M.
Cells 2021, 10(3), 540; https://doi.org/10.3390/cells10030540 

2. “Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives”
Raffaele, S.; Boccazzi, M.; Fumagalli, M.
Cells 2021, 10(3), 565; https://doi.org/10.3390/cells10030565

3. “Neuroprotective Natural Products for Alzheimer’s Disease”
Chen, X.; Drew, J.; Berney, W.; Lei, W.
Cells 2021, 10(6), 1309; https://doi.org/10.3390/cells10061309

4. “Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications”
Mithaiwala, M.N.; Santana-Coelho, D.; Porter, G.A.; O’Connor, J.C.
Cells 2021, 10(6), 1548; https://doi.org/10.3390/cells10061548

5. “Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway”
Vallée, A.; Vallée, J.-N.; Lecarpentier, Y.
Cells 2021, 10(2), 230; https://doi.org/10.3390/cells10020230

6. “Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?”
Scaricamazza, S.; Salvatori, I.; Ferri, A.; Valle, C.
Cells 2021, 10(3), 525; https://doi.org/10.3390/cells10030525

7. “Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control”
Speranza, L.; di Porzio, U.; Viggiano, D.; de Donato, A.; Volpicelli, F.
Cells 2021, 10(4), 735; https://doi.org/10.3390/cells10040735

8. “Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease”
Shukla, P.K.; Delotterie, D.F.; Xiao, J.; Pierre, J.F.; Rao, R.; McDonald, M.P.; Khan, M.M.
Cells 2021, 10(4), 779; https://doi.org/10.3390/cells10040779

9. “Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma”
Tribble, J.R.; Hui, F.; Jöe, M.; Bell, K.; Chrysostomou, V.; Crowston, J.G.; Williams, P.A.
Cells 2021, 10(2), 295; https://doi.org/10.3390/cells10020295

10. “NMDA and AMPA Receptor Autoantibodies in Brain Disorders: From Molecular Mechanisms to Clinical Features”
Gardoni, F.; Stanic, J.; Scheggia, D.; Benussi, A.; Borroni, B.; Di Luca, M.
Cells 2021, 10(1), 77; https://doi.org/10.3390/cells10010077

Back to TopTop